by Hemalatha Rangarajan, MD
Dr. Hemalatha Rangarajan of Nationwide Children’s Hospital (Columbus, Ohio) discusses new CIBMTR findings on pediatric and young adult AML, showing that extramedullary disease (EMD) at...
by Jacob Keller, Chenyu Lin
Cell and gene therapy (CGT) is rapidly transforming modern medicine, requiring scalable infrastructure to support its growing use across cancer and non-malignant diseases. This article highlights...
by Alex Kadhim
Researchers from the University of Lausanne and University Hospital of Zurich in Switzerland demonstrate that PD‑1–targeted CAR‑T cells can selectively reduce HIV reservoir cells and delay...
by Alex Kadhim
Researchers from leading institutions in Shanghai, China, identified a key immune signature driving steroid‑refractory acute graft‑versus‑host disease (SR‑aGvHD), involving expanded CD28+ CD8+...
by ASTCT Talks and Oncology On the Go
In a special ASTCT Talks and Oncology on the Go collaboration, experts discuss a case study examining how CAR T-cell therapy may contribute to rare gastrointestinal T-cell lymphomas. The...
by Margy MacMillan
Last year, Transplantation and Cellular Therapy, ASTCT’s journal, celebrated its 30th year serving the profession. This milestone caused me to reflect on what the journal has meant to the...